Corcept Therapeutics | CORT - Себестоимость





Себестоимость Изменить Дата
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Alaunos Therapeutics USD 0 18K 2024-09
ANI Pharmaceuticals USD 114.5M 8.38M 2026-03
Ardelyx USD 4.81M 6.04M 2026-03
Aurora Cannabis CAD 8.22M 80.38M 2026-03
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Canopy Growth CAD 62.98M 9.91M 2026-03
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Eli Lilly USD 3.58B 205M 2026-03
J&J USD 8B 67M 2026-06
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Merck USD 2.94B 380M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.71B 251M 2026-06
Novartis USD 3.46B 83M 2026-03
Omeros USD 33.16M 18.52M 2024-06
Pacira USD 50.74M 3.89M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
TG Therapeutics USD 33.51M 4.63M 2026-03